炎症微环境与肿瘤关系的研究进展
摘要
关键词
全文:
PDF参考
[1]Philip M, Schietinger A. CD8(+) T cell differentiation and dysfunction in cancer [J]. Nat Rev Immunol, 2022, 22(4): 209-23.[2]van der Leun A M, Thommen D S, Schumacher T N. CD8(+) T cell states in human cancer: insights from single-cell analysis [J]. Nat Rev Cancer, 2020, 20(4): 218-32.[3]Borst J, Ahrends T, Babala N, et al. CD4(+) T cell help in cancer immunology and immunotherapy [J]. Nat Rev Immunol, 2018, 18(10): 635-47.[4]Togashi Y, Shitara K, Nishikawa H. Regulatory T cells in cancer immunosuppression - implications for anticancer therapy [J]. Nat Rev Clin Oncol, 2019, 16(6): 356-71.[5]Laumont C M, Banville A C, Gilardi M, et al. Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities [J]. Nat Rev Cancer, 2022, 22(7): 414-30.[6]Chan I S, Ewald A J. The changing role of natural killer cells in cancer metastasis [J]. J Clin Invest, 2022, 132(6).[7]Guc E, Pollard J W. Redefining macrophage and neutrophil biology in the metastatic cascade [J]. Immunity, 2021, 54(5): 885-902.[8]Jaillon S, Ponzetta A, Di Mitri D, et al. Neutrophil diversity and plasticity in tumour progression and therapy [J]. Nat Rev Cancer, 2020, 20(9): 485-503.[9]Blomberg O S, Spagnuolo L, Garner H, et al. IL-5-producing CD4(+) T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer [J]. Cancer Cell, 2023, 41(1): 106-23 e10.[10]Grisaru-Tal S, Rothenberg M E, Munitz A. Eosinophil-lymphocyte interactions in the tumor microenvironment and cancer immunotherapy [J]. Nat Immunol, 2022, 23(9): 1309-16.[11]Majorini M T, Colombo M P, Lecis D. Few, but Efficient: The Role of Mast Cells in Breast Cancer and Other Solid Tumors [J]. Cancer Res, 2022, 82(8): 1439-47.[12]Rozenblatt-Rosen O, Regev A, Oberdoerffer P, et al. The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution [J]. Cell, 2020, 181(2): 236-49.[13]Mascaux C, Angelova M, Vasaturo A, et al. Immune evasion before tumour invasion in early lung squamous carcinogenesis [J]. Nature, 2019, 571(7766): 570-+.[14]Pylaeva E, Korschunow G, Spyra I, et al. During early stages of cancer, neutrophils initiate anti-tumor immune responses in tumor-draining lymph nodes [J]. Cell Rep, 2022, 40(7): 111171.
DOI: http://dx.doi.org/10.12361/2661-3603-06-06-159826
Refbacks
- 当前没有refback。